N/A Completed N=20 Single-blind Treatment

Treatments of Acquired Apraxia of Speech

aphasia · Apraxia of Speech · Stroke

Source: ClinicalTrials.gov NCT01483807 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2019

Primary outcomePrimary: Speech Production: Effect Size for Treated Items — 6.84; 6.14 effect size — p=.254

Summary

This study was designed to examine the effects of speech therapy on ability to produce speech sounds in persons with acquired apraxia of speech.

Outcome Measures

Outcome	Result	p-value
PRIMARY Speech Production: Effect Size for Treated Items	6.84; 6.14	.254
PRIMARY Speech Production: Percent Change in Treated Items	46; 38	.043 sig
SECONDARY Speech Production: Percent Change in Untrained Items	14; 13	.396
SECONDARY Speech Production of Untrained Items: Effect Sizes for Untrained Items	2.56; 2.11	.212

Eligibility Criteria

Inclusion Criteria

Must have acquired apraxia of speech that occurred following a stroke or other brain injury.
Must be at least 6 months post-onset of brain injury.
May have aphasia.

Exclusion Criteria

History of drug or alcohol abuse.
History of mental illness.
Neurological condition other than that which resulted in apraxia of speech.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01483807). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.